Barriers, frameworks, and mitigating strategies influencing the dissemination and implementation of health promotion interventions in indigenous communities: a scoping review.
Cultural context
Dissemination frameworks
Implementation barriers
Indigenous communities
SISTER strategies
Journal
Implementation science : IS
ISSN: 1748-5908
Titre abrégé: Implement Sci
Pays: England
ID NLM: 101258411
Informations de publication
Date de publication:
21 Feb 2022
21 Feb 2022
Historique:
received:
21
07
2021
accepted:
18
01
2022
entrez:
22
2
2022
pubmed:
23
2
2022
medline:
3
5
2022
Statut:
epublish
Résumé
Many Indigenous communities across the USA and Canada experience a disproportionate burden of health disparities. Effective programs and interventions are essential to build protective skills for different age groups to improve health outcomes. Understanding the relevant barriers and facilitators to the successful dissemination, implementation, and retention of evidence-based interventions and/or evidence-informed programs in Indigenous communities can help guide their dissemination. To identify common barriers to dissemination and implementation (D&I) and effective mitigating frameworks and strategies used to successfully disseminate and implement evidence-based interventions and/or evidence-informed programs in American Indian/Alaska Native (AI/AN), Native Hawaiian/Pacific Islander (NH/PI), and Canadian Indigenous communities. A scoping review, informed by the York methodology, comprised five steps: (1) identification of the research questions; (2) searching for relevant studies; (3) selection of studies relevant to the research questions; (4) data charting; and (5) collation, summarization, and reporting of results. The established D&I SISTER strategy taxonomy provided criteria for categorizing reported strategies. Candidate studies that met inclusion/exclusion criteria were extracted from PubMed (n = 19), Embase (n = 18), and Scopus (n = 1). Seventeen studies were excluded following full review resulting in 21 included studies. The most frequently cited category of barriers was "Social Determinants of Health in Communities." Forty-three percent of barriers were categorized in this community/society-policy level of the SEM and most studies (n = 12, 57%) cited this category. Sixteen studies (76%) used a D&I framework or model (mainly CBPR) to disseminate and implement health promotion evidence-based programs in Indigenous communities. Most highly ranked strategies (80%) corresponded with those previously identified as "important" and "feasible" for D&I The most commonly reported SISTER strategy was "Build partnerships (i.e., coalitions) to support implementation" (86%). D&I frameworks and strategies are increasingly cited as informing the adoption, implementation, and sustainability of evidence-based programs within Indigenous communities. This study contributes towards identifying barriers and effective D&I frameworks and strategies critical to improving reach and sustainability of evidence-based programs in Indigenous communities. N/A (scoping review).
Sections du résumé
BACKGROUND
BACKGROUND
Many Indigenous communities across the USA and Canada experience a disproportionate burden of health disparities. Effective programs and interventions are essential to build protective skills for different age groups to improve health outcomes. Understanding the relevant barriers and facilitators to the successful dissemination, implementation, and retention of evidence-based interventions and/or evidence-informed programs in Indigenous communities can help guide their dissemination.
PURPOSE
OBJECTIVE
To identify common barriers to dissemination and implementation (D&I) and effective mitigating frameworks and strategies used to successfully disseminate and implement evidence-based interventions and/or evidence-informed programs in American Indian/Alaska Native (AI/AN), Native Hawaiian/Pacific Islander (NH/PI), and Canadian Indigenous communities.
METHODS
METHODS
A scoping review, informed by the York methodology, comprised five steps: (1) identification of the research questions; (2) searching for relevant studies; (3) selection of studies relevant to the research questions; (4) data charting; and (5) collation, summarization, and reporting of results. The established D&I SISTER strategy taxonomy provided criteria for categorizing reported strategies.
RESULTS
RESULTS
Candidate studies that met inclusion/exclusion criteria were extracted from PubMed (n = 19), Embase (n = 18), and Scopus (n = 1). Seventeen studies were excluded following full review resulting in 21 included studies. The most frequently cited category of barriers was "Social Determinants of Health in Communities." Forty-three percent of barriers were categorized in this community/society-policy level of the SEM and most studies (n = 12, 57%) cited this category. Sixteen studies (76%) used a D&I framework or model (mainly CBPR) to disseminate and implement health promotion evidence-based programs in Indigenous communities. Most highly ranked strategies (80%) corresponded with those previously identified as "important" and "feasible" for D&I The most commonly reported SISTER strategy was "Build partnerships (i.e., coalitions) to support implementation" (86%).
CONCLUSION
CONCLUSIONS
D&I frameworks and strategies are increasingly cited as informing the adoption, implementation, and sustainability of evidence-based programs within Indigenous communities. This study contributes towards identifying barriers and effective D&I frameworks and strategies critical to improving reach and sustainability of evidence-based programs in Indigenous communities.
REGISTRATION NUMBER
BACKGROUND
N/A (scoping review).
Identifiants
pubmed: 35189904
doi: 10.1186/s13012-022-01190-y
pii: 10.1186/s13012-022-01190-y
pmc: PMC8862215
doi:
Types de publication
Journal Article
Review
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
18Subventions
Organisme : NIMHD NIH HHS
ID : R21 MD013960
Pays : United States
Informations de copyright
© 2022. The Author(s).
Références
Prev Sci. 2020 Jan;21(Suppl 1):54-64
pubmed: 30397737
Prev Sci. 2020 Jan;21(Suppl 1):74-82
pubmed: 30284158
J Psychoactive Drugs. 2011 Oct-Dec;43(4):291-6
pubmed: 22400459
J Health Dispar Res Pract. 2016 Fall;9(3):168-180
pubmed: 27818849
Implement Sci. 2013 Dec 01;8:139
pubmed: 24289295
Can Respir J. 2013 Jul-Aug;20(4):295-300
pubmed: 23936889
J Psychoactive Drugs. 2011 Oct-Dec;43(4):309-18
pubmed: 22400462
Am J Community Psychol. 2008 Jun;41(3-4):171-81
pubmed: 18302018
Cultur Divers Ethnic Minor Psychol. 2019 Jan;25(1):44-54
pubmed: 30714766
Front Public Health. 2018 Aug 17;6:225
pubmed: 30175091
Health Place. 2013 Nov;24:183-9
pubmed: 24140703
Trials. 2011 May 18;12:126
pubmed: 21592347
J Ethn Subst Abuse. 2007;6(2):41-8
pubmed: 18192203
Health Commun. 2021 Aug 22;:1-18
pubmed: 34420460
J Consult Clin Psychol. 2009 Aug;77(4):751-62
pubmed: 19634967
J Sch Psychol. 2019 Oct;76:66-77
pubmed: 31759470
Implement Sci. 2015 Apr 21;10:53
pubmed: 25895742
NCHS Data Brief. 2018 Aug;(318):1-8
pubmed: 30156535
Infant Ment Health J. 2018 May;39(3):276-286
pubmed: 29800487
BMJ. 1996 Jan 13;312(7023):71-2
pubmed: 8555924
Can J Public Health. 2014 May 30;105(4):e296-305
pubmed: 25166133
Am J Prev Med. 2012 Sep;43(3):337-50
pubmed: 22898128
BMC Geriatr. 2017 Jul 14;17(1):147
pubmed: 28709402
BMC Psychiatry. 2016 Oct 21;16(1):357
pubmed: 27769204
Int J Circumpolar Health. 2012 Jul 20;71:18833
pubmed: 22818719
J Sch Health. 2014 Jan;84(1):25-32
pubmed: 24320149
Rural Remote Health. 2018 Apr;18(2):4317
pubmed: 29724108
J Prim Prev. 2018 Feb;39(1):59-70
pubmed: 29344773
J Psychoactive Drugs. 2011 Oct-Dec;43(4):269-75
pubmed: 22400456
Lancet Diabetes Endocrinol. 2015 May;3(5):319
pubmed: 25794929
Diabetes Care. 2013 Jul;36(7):2027-34
pubmed: 23275375
Hawaii J Med Public Health. 2017 Jul;76(7):190-198
pubmed: 28721313
Behav Ther. 2018 Jul;49(4):525-537
pubmed: 29937255
MMWR Morb Mortal Wkly Rep. 2018 Nov 30;67(47):1314-1318
pubmed: 30496159
Health Promot Pract. 2010 Nov;11(6):888-99
pubmed: 19376928
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Transl Behav Med. 2014 Jun;4(2):149-59
pubmed: 24904698
JMIR Res Protoc. 2016 Nov 21;5(4):e225
pubmed: 27872037
Am J Public Health. 2014 Sep;104 Suppl 4:S548-54
pubmed: 25100420
J Psychoactive Drugs. 2011 Oct-Dec;43(4):276-81
pubmed: 22400457
J Public Health Med. 1999 Jun;21(2):133-9
pubmed: 10432240
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
Child Maltreat. 2012 Aug;17(3):242-52
pubmed: 22927674
Adm Policy Ment Health. 2015 Jan;42(1):29-39
pubmed: 24242820
Prev Med. 2014 Oct;67 Suppl 1:S51-7
pubmed: 24513172
Implement Sci. 2017 Jul 28;12(1):97
pubmed: 28754140
Pimatisiwin. 2009 Jun 1;7(1):1
pubmed: 20150951
Prev Sci. 2019 Aug;20(6):914-935
pubmed: 31152328
Birth Defects Res. 2019 Jul 15;111(12):835-847
pubmed: 30790478
J Public Health Manag Pract. 2004 Jan-Feb;10(1):46-53
pubmed: 15018341
Ethn Health. 2021 Apr;26(3):352-363
pubmed: 30146899
Implement Sci. 2013 Feb 17;8:22
pubmed: 23414420
Educ Health (Abingdon). 2008 Dec;21(3):174
pubmed: 19967637
Transl Behav Med. 2017 Sep;7(3):427-434
pubmed: 28585164
Health Res Policy Syst. 2017 Feb 23;15(1):15
pubmed: 28231801